Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE
|
BSE: 532321
|
ISIN: INE010B01027
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
878.6500
4.95
(
0.57
%)
NSE
May 09, 2025
15:31 PM
33.65% Fall from 52W High
Volume:
783.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Zydus Lifesciences Ltd.
06 Feb 2025
US FDA Approval
878.65
0.57%
ZYDUS LIFESCIENCES L
Accumulate:
Zydus Lifesciences Ltd.
by
Prabhudas Lilladhar
Target: 1050 | Upside : 19.5%
Target
Prabhudas Lilladhar
Zydus Lifesciences Ltd. is trading
below its 50 day SMA
of 882.6
More from Zydus Lifesciences Ltd.
Recommended
Five Interesting Stocks Today - May 09, 2025
The Baseline |
09 May 2025, 04:56PM
Market closes lower, Intellect Design Arena's Q4 net profit surges 93% QoQ to Rs 135.3 crore
Trendlyne Marketwatch |
09 May 2025, 03:56PM
Earnings Call Transcript - Cadila Healthcare
|
14 Feb 2020